Brno, Czech Republic April 25, 2024 --(PR.com)-- Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof's innovative molecular diagnostic technologies. “Entering into the partnership with ALPCO-GeneProof, EUROIMMUN is relying on an established and experienced provider for molecular diagnostic assays. It will allow EUROIMMUN’s customers to benefit from a vastly expanded high-quality assay portfolio that can be run on established real-time PCR cyclers,” says Dirk Beecker, CEO of EUROIMMUN. Erik Allen, CEO of ALPCO-GeneProof, expressed confidence about the partnership, stating, "Having EUROIMMUN as a partner brings a strong focus to the European Union for the GeneProof products. Combining our high-quality IVDR cleared kits with their expertise in the diagnostic space and strong commercial presence means more customers can access the ...